Back
Agios Pharmaceuticals Vs. Arvinas Industry Stock Comparison
Sell
24
AGIO
Agios Pharmaceuticals
Last Price:
41.31
Seasonality Move:
0.18%
Sell
21
ARVN
Arvinas
Last Price:
24.95
Seasonality Move:
69.87%
Sell
24
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $40.56. The Score for AGIO is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- AGIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
21
Arvinas (ARVN)
is a Sell
Is Arvinas a Buy, Sell or Hold?
- The current Arvinas [ARVN] share price is $24.47. The Score for ARVN is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- ARVN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $40.56
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGIO is experiencing selling pressure, which indicates risk of future bearish movement.
ARVN Stock Price Chart
AGIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.63 | Sell |
| Relative Strength Index (14 RSI): | 34.39 | Sell |
| Chaikin Money Flow: | -393176 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.28 - 46.96) | Sell |
| Bollinger Bands (100): | (39.66 - 47.96) | Sell |
ARVN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 45.7 | Sell |
| Chaikin Money Flow: | 165464 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.4 - 25.54) | Sell |
| Bollinger Bands (100): | (24.02 - 30.24) | Sell |
AGIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.82 | Sell |
| 20-day SMA: | 45.14 | Sell |
| 50-day SMA: | 45.24 | Sell |
| 200-day SMA: | 35.73 | Buy |
| 8-day EMA: | 43.69 | Sell |
| 20-day EMA: | 44.81 | Sell |
| 50-day EMA: | 44.75 | Sell |
| 200-day EMA: | 38.02 | Buy |
ARVN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.51 | Sell |
| 20-day SMA: | 24.82 | Sell |
| 50-day SMA: | 25.41 | Sell |
| 200-day SMA: | 33.86 | Sell |
| 8-day EMA: | 24.64 | Sell |
| 20-day EMA: | 24.85 | Sell |
| 50-day EMA: | 25.67 | Sell |
| 200-day EMA: | 29.59 | Sell |
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $7.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.55 per share, and a decrease next year of $7.11 per share.
Arvinas Earnings Growth & ARVN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.65 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.66 per share, and a decrease next year of $1.40 per share.
Agios Pharmaceuticals Technical Analysis
| Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arvinas Technical Analysis
| Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||